The Innovative Medicines Initiative (IMI) launched its 11th call for proposals on December 11th, 2013. The call features eight topics including the « European platform for proof of concept for prevention in Alzheimers Disease » (EPOC-AD).
EPOC-AD calls for greater cooperation and collaboration between academia, government and industry to enhance the drug development process.
The project would create a precompetitive space to enable collaboration for optimising patient selection, clinical trials methodologies and candidate therapies, as well as conducting adaptive clinical trials that will produce the greatest likelihood of success.